Patents by Inventor Jo-Anne S. Hongo

Jo-Anne S. Hongo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR HEMATOPOIETIC ORIGIN
    Publication number: 20170362318
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: January 13, 2017
    Publication date: December 21, 2017
    Inventors: Craig Crowley, Frederic J. De Sauvage, Dan L. Eaton, Allen Ebens, JR., Kristi Elkins, Jo-Anne S. Hongo, Jagath Reddy Junutula, Andrew Polson, Sarajane Ross, Victoria Smith, Richard L. Vandlen, Bing Zheng
  • COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
    Publication number: 20170129963
    Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: September 15, 2016
    Publication date: May 11, 2017
    Applicant: Genentech, Inc.
    Inventors: Sunil Bhakta, Meredith C. Hazen, Jo-Anne S. Hongo, Jagath R. Junutula
  • Compositions and methods for the diagnosis and treatment of tumor
    Patent number: 9580514
    Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same. In certain aspects, the isolated nucleic acid molecule comprises a nucleotide sequence having at least about 80% nucleic acid sequence identity, alternatively at least about 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% nucleic acid sequence identity, to (a) a DNA molecule encoding a full-length TAT polypeptide having an amino acid sequence as disclosed herein, a TAT polypeptide amino acid sequence lacking the signal peptide as disclosed herein, an extracellular domain of a transmembrane TAT polypeptide, with or without the signal peptide, as disclosed herein.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: February 28, 2017
    Assignee: Genentech, Inc.
    Inventors: Sunil Bhakta, Meredith Hazen, Jo-Anne S Hongo, Jagath R Junutula, Isidro Hotzel, Yonglei Shang, Shang-Fan Yu
  • ANTI-CRTH2 ANTIBODIES AND METHODS OF USE
    Publication number: 20160090422
    Abstract: The invention provides anti-CRTh2 antibodies and methods of using the same.
    Type: Application
    Filed: September 14, 2015
    Publication date: March 31, 2016
    Inventors: Karin REIF, Isidro HOTZEL, Jo-Anne S. HONGO, Tao HUANG, Yonglei SHANG, Meredith HAZEN
  • ANTIBODY COMPOSITIONS AND METHODS OF USE
    Publication number: 20150376265
    Abstract: The invention provides compositions comprising anti-gH antibodies and anti-Complex I antibodies as well as methods of using the same.
    Type: Application
    Filed: December 19, 2014
    Publication date: December 31, 2015
    Applicant: GENENTECH, INC.
    Inventors: Xiaocheng Chen, Mark Dennis, Becket L. Feierbach, Ashley Fouts, Isidro Hotzel, Bing Li, Jo-Anne S. Hongo, Rajesh Vij
  • COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
    Publication number: 20150098946
    Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same. In certain aspects, the isolated nucleic acid molecule comprises a nucleotide sequence having at least about 80% nucleic acid sequence identity, alternatively at least about 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% nucleic acid sequence identity, to (a) a DNA molecule encoding a full-length TAT polypeptide having an amino acid sequence as disclosed herein, a TAT polypeptide amino acid sequence lacking the signal peptide as disclosed herein, an extracellular domain of a transmembrane TAT polypeptide, with or without the signal peptide, as disclosed herein.
    Type: Application
    Filed: March 14, 2013
    Publication date: April 9, 2015
    Applicant: Genentech, Inc.
    Inventors: Sunil Bhakta, Meredith Hazen, Jo-Anne S Hongo, Jagath R Junutula, Isidro Hotzel, Yonglei Shang, Shang-Fan Yu
  • Anti-neuropilin antibodies and methods of use
    Patent number: 8993249
    Abstract: The invention provides anti-NRP1 antibodies and methods of using the same.
    Type: Grant
    Filed: January 9, 2013
    Date of Patent: March 31, 2015
    Assignee: Genentech, Inc.
    Inventors: Maike Schmidt, Christopher Adam Callahan, Jo-Anne S. Hongo, Hartmut Koeppen, Ryan J. Watts
  • ANTI-CRTH2 ANTIBODIES AND METHODS OF USE
    Publication number: 20140328849
    Abstract: The invention provides anti-CRTh2 antibodies and methods of using the same.
    Type: Application
    Filed: March 14, 2014
    Publication date: November 6, 2014
    Applicant: GENENTECH, INC.
    Inventors: Karin REIF, Isidro HOTZEL, Jo-Anne S. HONGO, Tao HUANG, Yonglei SHANG, Meredith HAZEN
  • Compositions and methods for modulating vascular development
    Patent number: 8790646
    Abstract: The present invention provides methods of using EGFL7 antagonist to modulate vascular development. Also provided herein are methods of screening for modulators of EGFL7 activity. Furthermore, methods of treatment using EGFL7 antagonists are provided.
    Type: Grant
    Filed: October 14, 2010
    Date of Patent: July 29, 2014
    Assignee: Genentech Inc.
    Inventors: Ellen Filvaroff, Weilan Ye, Leon H. Parker, IV, Jo-Anne S. Hongo, Maike Schmidt
  • NLRR-1 antagonists and uses thereof
    Patent number: 8691222
    Abstract: NLRR-1 antagonists and methods of their use in treating cancer and other disorders are provided.
    Type: Grant
    Filed: October 1, 2008
    Date of Patent: April 8, 2014
    Assignee: Genentech, Inc.
    Inventors: Meredith Hazen, Jo-Anne S. Hongo, Victoria Smith, Susanna Stinson
  • Compositions and methods for the treatment of tumor of hematopoietic origin
    Patent number: 8388973
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Grant
    Filed: December 30, 2010
    Date of Patent: March 5, 2013
    Assignee: Genentech, Inc.
    Inventors: Wesley Chang, Frederic J. de Sauvage, Dan L. Eaton, Allen J. Ebens, Jr., Gretchen Frantz, Jo-Anne S. Hongo, Hartmut Koeppen, Andrew Polson, Victoria Smith
  • COMPOSITIONS AND METHODS FOR MODULATING VASCULAR DEVELOPMENT
    Publication number: 20120003208
    Abstract: The present invention provides methods of using EGFL7 antagonist to modulate vascular development. Also provided herein are methods of screening for modulators of EGFL7 activity. Furthermore, methods of treatment using EGFL7 antagonists are provided.
    Type: Application
    Filed: October 14, 2010
    Publication date: January 5, 2012
    Applicant: Genentech, Inc.
    Inventors: Ellen Filvaroff, Weilan Ye, Leon H. Parker, IV, Jo-Anne S. Hongo, Maike Schmidt
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN
    Publication number: 20110268657
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: December 30, 2010
    Publication date: November 3, 2011
    Inventors: Wesley Chang, Frederic J. de Sauvage, Dan L. Eaton, Allen J. Ebens, JR., Gretchen Frantz, Jo-Anne S. Hongo, Hartmut Koeppen, Andrew Polson, Victoria Smith
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN
    Publication number: 20110206658
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: October 12, 2010
    Publication date: August 25, 2011
    Inventors: Craig Crowley, Frederic J. de Sauvage, Dan L. Eaton, Allen Ebens, JR., Kristi Elkins, Jo-Anne S. Hongo, Jagath Reddy Juntula, Andrew Polson, Sarajane Ross, Victoria Smith, Richard L. Vandlen, Bing Zheng
  • Compositions and Methods Relating to STOP-1
    Publication number: 20110112279
    Abstract: The present invention provides novel polypeptides, antibodies, antagonists, agonists, potentiators, nucleic acid molecules, compositions and methods relating to the STOP-1 polypeptide that are useful for treating and preventing diseases and for medical diagnosis and research. The present invention also provides consensus sequences and specific sequences for antibodies that specifically bind to STOP-1 that are useful in the methods described herein.
    Type: Application
    Filed: July 28, 2010
    Publication date: May 12, 2011
    Applicant: Genentech, Inc.
    Inventors: HEIDI ACKERLY, Avi Ashkenazi, David Eberhard, Gretchen Frantz, Dorothy French, Germaine G. Fuh, Jo-Anne S. Hongo, Chingwei V. Lee, Scot A. Marsters, Helga A. Raab, Evgeny Varfolomeev, Beni B. Wolf, Robert Maurice Pitti, Liliana Soroceanu
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC
    Publication number: 20110070243
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: September 9, 2010
    Publication date: March 24, 2011
    Inventors: CRAIG CROWLEY, FREDERIC J. DE SAUVAGE, DAN L. EATON, ALLEN EBENS, JR., KRISTI ELKINS, JO-ANNE S. HONGO, JAGATH REDDY JUNUTULA, ANDREW POLSON, SARAJANE ROSS, VICTORIA SMITH, RICHARD L. VANDLEN, BING ZHENG
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN
    Publication number: 20110042260
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: August 12, 2010
    Publication date: February 24, 2011
    Inventors: Craig Crowley, Frederic J. de Sauvage, Dan L. Eaton, Allen Ebens, JR., Jo-Anne S. Hongo, Andrew Polson, Sarajane Ross, Victoria Smith, Richard L. Vandlen
  • Compositions and methods for the treatment of tumor of hematopoietic origin
    Patent number: 7888478
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Grant
    Filed: December 21, 2005
    Date of Patent: February 15, 2011
    Assignee: Genentech, Inc.
    Inventors: Wesley Chang, Frederic J. de Sauvage, Dan L. Eaton, Allen J. Ebens, Jr., Gretchen Frantz, Jo-Anne S. Hongo, Hartmut Koeppen, Andrew Polson, Victoria Smith
  • NLRR-1 ANTAGONISTS AND USES THEREOF
    Publication number: 20100330082
    Abstract: NLRR-1 antagonists and methods of their use in treating cancer and other disorders are provided.
    Type: Application
    Filed: October 1, 2008
    Publication date: December 30, 2010
    Applicant: GENENTECH INC.
    Inventors: Meredith Hazen, Jo-Anne S. Hongo, Victoria Smith, Susanna Stinson
  • Compositions and methods relating to STOP-1
    Patent number: 7799899
    Abstract: The present invention provides novel polypeptides, antibodies, antagonists, agonists, potentiators, nucleic acid molecules, compositions and methods relating to the STOP-1 polypeptide that are useful for treating and preventing diseases and for medical diagnosis and research. The present invention also provides consensus sequences and specific sequences for antibodies that specifically bind to STOP-1 that are useful in the methods described herein.
    Type: Grant
    Filed: April 16, 2004
    Date of Patent: September 21, 2010
    Assignee: Genentech, Inc.
    Inventors: Heidi Ackerly, Avi Ashkenazi, David Eberhard, Gretchen Frantz, Dorothy French, Germaine G. Fuh, Jo-Anne S. Hongo, Chingwei V. Lee, Scot A. Masters, Helga A. Raab, Evgeny Varfolomeev, Beni B. Wolf, Robert Maurice Pitti, Liliana Soroceanu